Leeuwarden / Beetsterzwaag – September 1, 2026
Investment firm Oersjoch and Leeuwarden-based company Biotrack BV are joining forces. With this investment, Biotrack, and its laboratory brand NL-LAB & VET-LAB, will have the scope to grow further and roll out its technology internationally.
Faster insight, better care
Based in Leeuwarden, Biotrack is developing a new standard in microbiological research. With its patented C-FISH method, the company provides insights within an hour where traditional microbiology takes days, for example, to determine which antibiotic treatment is effective. In the fight against the globally growing problem of antibiotic resistance, that speed can make all the difference.
The heart of this technology is C-FISH: a patented method that not only detects microorganisms but also maps what they do and how active they are.
That depth also makes the technique valuable for other applications, such as research into the human and veterinary gut microbiome, which plays an increasingly important role in both physical and mental health.
NL-LAB, Biotrack's laboratory brand, translates this technology into daily practice. Through NL-LAB, doctors, therapists, and other healthcare professionals gain access to in-depth analyses, translated into clear reports that they can act upon immediately. The technology also proves its value in sports: for instance, Biotrack and NL-LAB previously collaborated with speed skating team Novus and conducted research with football players from Cambuur.
A logical match
